🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 17166A101 (prev. 13173L107 )
- Market Cap
- Micro Cap
- IPO
- $8.00/share
- Previous Symbol
- CLXT (changed 6/2/2023)
- Previous Name
- Calyxt, Inc.
Business: Calyxt, Inc. is Cellectis’ majority owned gene editing agriculture company. Cellectis intends to retain majority ownership of Calyxt. Calyxt is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics.
Notes: April 7, 2023 -- Calyxt, Inc. (Nasdaq: CLXT) today announced that it will proceed with the 1-for-10 reverse stock split previously approved by the Company’s shareholders at the annual meeting of shareholders on June 1, 2022. Calyxt plans to file an amendment to its certificate of incorporation to effectuate the reverse stock split after the close of trading on April 24, 2023, and Calyxt’s common stock, par value $0.0001 per share, will begin trading on an adjusted basis giving effect to the reverse stock split on April 25, 2023.
Company Contact
- CEO
- Peter Beetham
- CFO
- Cornelis Broos
- Headquarters
- 6455 Nancy Ridge Drive, San Diego, CA 92121
- Phone
- 858-450-0008
- Investor Relations
- Bill Koschak · 651-425-1754 · investors@calyxt.com